Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3323278
Max Phase: Preclinical
Molecular Formula: C38H34ClN5O13S2
Molecular Weight: 868.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3323278
Max Phase: Preclinical
Molecular Formula: C38H34ClN5O13S2
Molecular Weight: 868.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)OC[C@H]1O[C@@H](Sc2c(C#N)c(-c3ccc(Cl)cc3)c(C#N)c(=O)n2-c2ccc(S(=O)(=O)Nc3onc(C)c3C)cc2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
Standard InChI: InChI=1S/C38H34ClN5O13S2/c1-18-19(2)42-57-35(18)43-59(50,51)27-13-11-26(12-14-27)44-36(49)28(15-40)31(24-7-9-25(39)10-8-24)29(16-41)37(44)58-38-34(55-23(6)48)33(54-22(5)47)32(53-21(4)46)30(56-38)17-52-20(3)45/h7-14,30,32-34,38,43H,17H2,1-6H3/t30-,32-,33+,34-,38+/m1/s1
Standard InChI Key: GNPGLDWEEXXSKL-KMQJBDDJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 868.30 | Molecular Weight (Monoisotopic): 867.1283 | AlogP: 4.48 | #Rotatable Bonds: 12 |
Polar Surface Area: 256.21 | Molecular Species: ACID | HBA: 18 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 5.60 | CX Basic pKa: 1.66 | CX LogP: 3.08 | CX LogD: 2.18 |
Aromatic Rings: 4 | Heavy Atoms: 59 | QED Weighted: 0.15 | Np Likeness Score: -0.52 |
1. Nasr T, Bondock S, Eid S.. (2014) Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety., 84 [PMID:25050881] [10.1016/j.ejmech.2014.07.052] |
Source(1):